Modern cancer epidemiological research: Genetic polymorphisms and environment

Revista de Saude Publica

Volumn 39, Issue 3, 2005, Pages 490-497

  Wünsch Filho, Victor ^a   Zago, Marco A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Environmental risks; Epidemiology, molecular; Neoplasms, epidemiology; Polymorphism (genetics)

Indexed keywords

DNA; XENOBIOTIC AGENT;

ACCURACY; CANCER; CANCER GENETICS; CANCER RESEARCH; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CASE CONTROL STUDY; COHORT ANALYSIS; DNA REPAIR; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; EPIDEMIOLOGICAL DATA; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; MOLECULAR DYNAMICS; ONCOGENE; PREVALENCE; PROGNOSIS; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 23944448282     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0034-89102005000300023     Document Type: Review

References (41)

1. Awasthi YC, Sharma R, Singhal SS. Human glutathione S-transferases. Int J Biochem 1994;26:295-308.
2. Brennan P. Gene-environment interaction and etiology of cancer: what does it mean and how can we measure it? Carcinogenesis 2002;23:381-7.
3. Caporaso N, Rothman N, Wacholder S. Case-control studies of common alleles and environmental factors. Natl Cancer Inst Monogr 1999;26:25-30.
4. Cuzick J. Interaction, subgroup analysis and sample size. In: Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, Boffetta P, editors. Metabolic polymorphisms and susceptibility to cancer. Lyon: IARC Press; 1999. p. 109-21. [IARC Scientific Publications, 148]
5. Gattás GJF, Soares-Vieira JA. Cytochrome P450-2E1 and glutathione S-transferase mu polymorphisms among caucasians and mulattoes from Brazil. Occup Med 2000;50:508-11.
6. Gauderman WJ, Morrison JL. Evidence for age-specific genetic relative risks in lung cancer. Am J Epidemiol 2000;151:41-9.
7. Goldstein AM, Andrieu N. Detection of interaction involving identified genes: available study designs. Natl Cancer Inst Monogr 1999;26:49-54.
8. Hahn WC, Weinberg RA. Modelling the molecular circuitry of cancer. Nat Rev Cancer 2002;2:331-41.
9. Hatagima A. Genetic polymorphisms and metabolism of endocrine disruptors in cancer susceptibility. Cad Saúde Pública 2002;18:357-77.
10. Holtzman NA, Marteau TM. Will genetics revolutionize medicine? N Engl J Med 2000;343:141-4.
11. Hoover RN. Cancer. Nature, nurture, or both. N Engl J Med 2000;343:135-6.
12. Houlston RS. Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 1999;8:675-82.
13. Jourenkova-Mironova N, Wikman H, Bouchardy C, Voho A, Dayer P, Benhamou S, Hirnoven A. Role of glutathione S-transferase GSTMl, GSTM3, GSTPI end GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer. Pharmacogenetics 1998;8:495-502.
14. Kisberstis P, Roberts L. It's not just the genes. Science 2002;296:685.
15. Kuller LH. Circular epidemiology. Am J Epidemiol 1999;150:897-903.
16. Lang M, Pelkonen O. Metabolism of xenobiotics and chemical carcinogenesis. In: Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, Boffetta P, editors. Metabolic polymorphisms and susceptibility to cancer. Lyon: IARC Press; 1999. p. 13-22. [IARC Scientific Publications, 148]
17. Langholz B, Rothman N, Wacholder S, Thomas DC. Cohort studies for characterizing measured genes. Natl Cancer Inst Monogr 1999;26:39-42.
18. Le Marchand L, Sivaraman L, Pierce L, Seifried A, Lum A, Wilkens LR, Lau AF. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with hung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 1998;58:4858-63.
19. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343:78-85.
20. Lockhart DJ, Winzeler EA: Genomics, gene expression and DNA arrays. Nature 2000;405:827-36.
21. Nakachi K, Imai K, Hayashi S, Watanabe J, Kawajiri K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 1993;53:2994-9.
22. Nakachi K, Imai K, Hayashi S, Watanabe J, Kawajiri K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 1991;51:5177-80.
23. Narod SA, Foulkes WD. BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 2004;4:665-76.
24. Nyberg F. Hou SM, Hemminki K, Lambert B, Pershagen G. Glutathione S-transferase M1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls. Cancer Epidemiol Biomarkers Prev 1998;7:875-883.
25. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents. vol. VIII. Lyon: IARC Press; 2003. [IARC Scientific Publications, 155]
26. Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001;411:390-395.
27. Rothman N, Wacholder S, Caporaso NE, Garcia-Closas M, Buetow K, Fraumeni Jr JF. The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens. Biochim Biophys Acta 2001;1471:C1-C10.
28. Rothtman N, Garcia-Closas M, Stewart WT, Lubin J. The impact of misclassification in case-control studies of gene-interactions. In: Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, Boffetta P, editors. Metabolic polymorphisms and susceptibility to cancer. Lyon: IARC Press; 1999. p. 89-96. [IARC Scientific Publications, 148]
29. Schliephake H. Prognostic relevance of molecular markers of oral cancer: a review. Int J Oral Maxillofac Surg 2003;32:233-45.
30. Susser M. Separating heredity and environment. Am J Prev Med 1985;1:5-23.
31. Taningher M, Malacarne D, Izzotti A, Ugolini D, Parodis S. Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat Res 1999;436:227-61.
32. Tokuhata GK, Lilienfeld AM. Familial aggregation of lung cancer in humans. J Natl Cancer Inst 1963;30:289-312.
33. Tsugane S, de Souza JM, Costa ML Jr, Mirra AP, Gotlieb SL, Laurenti R, Watanabe S. Cancer incidence rates among Japanese immigrants in the city of Sao Paulo, Brazil, 1969-78. Cancer Causes Control 1990;1:189-193.
34. Tuma RS. Narrowing the field: identifying ways to improve SNP association studies. J Natl Cancer Inst 2004;96:94-5.
35. Vineis P. A self-fulfilling prophecy: are we understimating the role of the environment in gene-environment interaction researc? Int J Epidemiol 2004;33:945-6.
36. Whittemore AS, Nelson LM. Study design in genetic epidemiology: theoretical and practical considerations. Natl Cancer Inst Monogr 1999;26:61-9.
37. Wild CP, Law GT, Roman E. Molecular epidemiology and cancer: promising areas for future research in the post-genomic era. Mutat Res 2002;499:3-12.
38. Willet WC. Balancing life-style and genomics research for disease prevention. Science 2002;296:695-8.
39. Wood ME, Kelly K, Mullineaux LG, Bunn PA Jr. The inherited nature of lung cancer: a pilot study. Lung Cancer 2000;30:135-44.
40. Wünsch-Filho V, Boffetta P, Colin D, Moncau JE. Familial cancer aggregation and the risk of lung cancer. São Paulo Med J 2002;120:38-44.
41. Xu XP, Kelsey KT, Wiencke JK, Wain JC, Christiani DC. Cytochrome P450 CYP1A1 Mspl polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1996;5:687-92.